DOJ Charges 2 Execs In Generic Drug Price-Fixing Plot

The U.S. Department of Justice on Wednesday accused the former top executives of Heritage Pharmaceuticals of plotting to fix prices of antibiotics and diabetes treatments, marking the first charges in the...

Already a subscriber? Click here to view full article